General NCI Grant Information

• NCI Publishes Guidelines for Design of Phase I and Phase II Clinical Trials 
• Current NCI Requests for Proposals 
• Current NCI Program Announcements 
• General Information on NCI Funding, Training, and Career Development Opportunities  

Specific Grant Announcements  

• NOT-CA-12-014: Selection of Appropriate Funding Opportunity under the National Cancer Institute (NCI) Initiative Research Answers to NCI’s Provocative Questions 
• PA-09-197: Biomarkers for Early Detection of Hematopoietic Malignancies (R01) (Expires: Multiple Dates, See Announcement)
• PA-09-198: Biomarkers for Early Detection of Hematopoietic Malignancies (R21) (Expires: Multiple Dates, See Announcement)
• PA-10-031: Epigenetic Approaches in Cancer Epidemiology (R01)  
• PA-10-032: Epigenetic Approaches in Cancer Epidemiology (R21)  
• PA-10-125: Collaborative Research for Molecular and Genomic Studies of Behavior in Animal Models (R01)  
• PA-09-253: Image-guided Drug Delivery in Cancer (R01) 
• PA-11-158: Biomarkers of Infection-Associated Cancers (R01) (Expires 05/08/2014)
• PA-11-160: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) (Expires 05/08/2014)
• PAR-12-145: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) (09/08/2015)
• PAR-12-144: NCI Small Grants Program for Cancer Research (NCI Omnibus R03) (09/18/2015)
• PA-12-220: Biomarkers for Early Detection of Hematopoietic Malignancies (R21) (Expires: Multiple Dates, See Announcement)
• PA-12-221: Biomarkers for Early Detection of Hematopoietic Malignancies (R01) (Expires: Multiple Dates, See Announcement)

back to top